If You'd Invested $1,500 in D-Wave Quantum Stock 1 Year Ago, Here's How Much You'd Have Today

D-Wave Quantum (QBTS) has seen an outsized share-price rally—about 1,280% over the past year through Nov. 17, turning a $1,500 stake into roughly $20,700—on interest in quantum computing; however, it remains a nascent commercial hardware-and-services vendor with Q3 revenue of $3.7 million (up ~100% year-over-year) against a $140 million loss. The stock trades at an aggressive valuation (over 408x projected next-12-month sales), reflecting high growth expectations but substantial execution and capital risk. While offering pure-play exposure to quantum, Motley Fool’s analysts did not include D-Wave in their Stock Advisor top-10 picks and point investors toward less risky, more diversified alternatives.

Analysis

D-Wave Quantum (NYSE: QBTS) has delivered an outsized share-price rally—about 1,280% over the year through Nov. 17—turning a $1,500 stake into roughly $20,700 and outpacing peers such as IonQ and Quantum Computing Inc. The stock's momentum reflects investor interest in quantum computing as a pure-play hardware-and-services exposure.

The company reported third-quarter revenue of $3.7 million, roughly double year over year, alongside a GAAP loss of $140 million, consistent with a capital-intensive, hypergrowth profile. The shares trade at over 408 times projected next-12-month sales, a valuation the article characterizes as “extremely expensive,” highlighting significant execution and financing risk if revenue scale does not accelerate.

Market signals in the coverage are mildly negative and cautious, with a market-impact score of 0.25 and Motley Fool analysts omitting D-Wave from their top-10 picks, suggesting limited near-term endorsement from that retail-research channel. Given the company’s nascent commercial traction, high valuation and sizable losses, investors should treat QBTS as speculative and prioritize monitoring revenue trajectory, margin trends and cash-burn/capital-raise risk before increasing exposure.

Key Decisions for Investors

• Limit exposure to a small, speculative allocation rather than a core position given the >408x projected-sales valuation and significant losses
• Require clear evidence of scalable revenue and margin improvement (quarterly revenue growth, narrowing losses) before adding to positions
• Avoid initiating or increasing large positions at current prices; wait for valuation compression or specific execution milestones that de-risk the business
• Compare QBTS exposure to alternatives such as IonQ if seeking quantum exposure with different risk/reward profiles and monitor potential dilution from future capital raises